Cited by 197Psoriasis: Treatment and PathogenesisDermatology and Skin DiseasesSpondyloarthritis Studies and Treatments

Etiology and Pathogenesis of Psoriasis

Boehncke, Wolf-Henning·2015·Rheumatic Disease Clinics of North America

Abstract

Psoriasis is a common, chronic inflammatory skin disease most often appearing in the form of well-demarcated, scaly plaques. These lesions highlight the fundamental processes underlying its pathogenesis, namely, inflammation and epidermal hyperproliferation. Both phenomena are considered consequences of an intimate interplay between the innate and the adaptive immune system. This concept is supported by results of genetic studies, pointing toward the signaling pathways of nuclear factor-κB, interferon-γ, and interleukin (IL)-23 as well as antigen presentation as central axes of the psoriatic inflammation. Efficacy of biologics targeting tumor necrosis factor-α, IL-23, or IL-17 provides further evidence in favor of this model.

Integrity signals

Registry

Crossref · 10.1016/j.rdc.2015.07.013

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Psoriasis lesions are thicker and present as plaques sharply limited with silvery white scales.

    “While psoriasis can affect similar locations as SD, typical lesions in psoriasis are thicker and present as plaques sharply limited with silvery white scales [8,32].”

    From Seborrheic Dermatitis and Dandruff: A Comprehensive Review (2015) · cites this paper as [32]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boehncke, W.-H.
Affiliations
University of Geneva (CH)
Corresponding author
Boehncke, Wolf-Henning
Venue
Rheumatic Disease Clinics of North America
Publisher
Elsevier BV
Published
2015-11
Volume
41
Issue
4
Pages
665-675
ISSN
0889-857X (ISSN-L)
OpenAlex
W1826301003
Cited by
197
References
6
Citations by year
2026: 6 · 2025: 12 · 2024: 14 · 2023: 20 · 2022: 26 · 2021: 21 · 2020: 28 · 2019: 27 · 2018: 17 · 2017: 12 · 2016: 11 · 2015: 2
FWCI
1.32
Type
journal article
Language
en
Open access
closed
Locations
  • Rheumatic Disease Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
Keywords
psoriasis, pathogenesis, etiology, epidermal hyperproliferation, skin inflammation, innate-adaptive immune interaction, genetic susceptibility, NF-κB signaling, interferon-gamma, IL-23, antigen presentation, biologic therapy, TNF-α, IL-17
MeSH terms
Humans, Inflammation, Psoriasis, Skin, Cytokines, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review